Up to now, drugs used in therapy against AD and PD include cholinesterase inhibitors and NMDA receptor antagonist, such as rivastigmine, galantamine, and donepezil, which demonstrated a good efficacy and a low incidence of adverse effects. Here, BCHE is linked to Parkinson disease.